SARS-CoV-2 stays active in or on aerosols for up to 3 hours, copper for up to 4 hours, cardboard for up to 24 hours, and plastic and stainless steel for up to 2 to 3 days.
The rate of transmission seems to be what makes COVID-19 a more serious threat than an earlier iteration of a coronavirus outbreak, a transmission rate aided by carriers who are asymptomatic, according to a research letter in the New England Journal of Medicine (NEJM). The virus that causes COVID-19, SARS-CoV-2, was compared to SARS-CoV-1, which emerged in the early 2000s, but was quickly brought under control. SARS-CoV-1 is the human coronavirus most closely related to SARS-CoV-2.
The data in the NEJM letter-compiled by investigators with the National Institutes of Health (NIH), the US Centers for Disease Control and Prevention (CDC), the University of California, Los Angeles (UCLA), and Princeton University-were widely shared during the past two weeks, with the findings being placed on a preprint server.
Investigators found that SARS-CoV-2 stays active on surfaces for about the same duration as SARS-CoV-1. It’s detectable in or on aerosols for up to 3 hours, copper for up to 4 hours, cardboard for up to 24 hours, and plastic and stainless steel for up to 2 to 3 days. The estimated differences in the half-lives of the viruses was small except in the case of cardboard.
“We found that the stability of SARS-CoV-2 was similar to that of SARS-CoV-1 under the experimental circumstances tested,” the study states. “This indicates that differences in the epidemiologic characteristics of these viruses probably arise from other factors, including high viral loads in the upper respiratory tract and the potential for persons infected with SARS-CoV-2 to shed and transmit the virus while asymptomatic.”
The measures used to successfully control SARS-CoV-1 will have a tougher time against SARS-CoV-2, the NIH pointed out in a press release. SARS-CoV-1 was stopped by intensive contact tracing and case isolation measures. No cases have been detected since 2004.
“In contrast to SARS-CoV-1, most secondary cases of virus transmission of SARS-CoV-2 appear to be occurring in community settings rather than healthcare settings,” the NIH says. “However, healthcare settings are also vulnerable to the introduction and spread of SARS-CoV-2, and the stability of SARS-CoV-2 in aerosols and on surfaces likely contributes to transmission of the virus in healthcare settings.”
The findings mirror those in 2 other recent studies by Dutch and Japanese investigators that also point to the problem of asymptomatic carriers of COVID-19. Japanese researchers looked at the 634 passengers who tested positive for COVID-19 on the Diamond Princess cruise ship. They found that 17.9% of these passengers were asymptomatic. Dutch researchers estimate that the “the proportion of pre-symptomatic transmission was 48% (95%CI 32-67%) for Singapore and 62% (95%CI 50-76%) for Tianjin, China.”
Healing With Algorithms: AI's Impact on Epidemiology and Infection Control
April 2nd 2024Media in the US presents AI as both beneficial and risky. Positive coverage shows AI's potential through virtual assistants like Siri, while cautionary tales warn of misuse like misinformation and deepfakes. How does all this work in health care?
Four Years After COVID-19: What Has the Infection Prevention Community Learned?
March 15th 2024Four years ago today, March 15, 2020, the COVID-19 lockdown began, and since then, the world has undergone significant changes. It has been a terrifying experience for everyone, especially for the infection prevention community, both within and outside of the health care sector. However, a crucial question remains unanswered: What has the infection prevention community learned from this pandemic, and where does it go from here?
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.